**1. Introduction**

350 Chronic Obstructive Pulmonary Disease – Current Concepts and Practice

Windisch, W., Vogel M., Sorichter S., Hennings E., Bremer H., Hamm H., Matthys H., &

Windisch, W., S. Kostic, M. Dreher, J. C. Virchow, Jr., & S. Sorichter. (2005). Outcome of

ventilation aimed at a maximal reduction of Pa(CO2). Chest 128 (2):657-62. Windisch, W., Dreher M., Storre J. H., & Sorichter S. (2006). Nocturnal non-invasive positive

Windisch, W., Haenel M., Storre J. H., & Dreher M. (2009). High-intensity non-invasive

reduces subsequent spontaneous PaCO2. Respir Med 96 (8):572-9.

Neurobiol 150 (2-3):251-60.

Virchow J. C., Jr. (2002). Normocapnia during nIPPV in chronic hypercapnic COPD

patients with stable COPD receiving controlled noninvasive positive pressure

pressure ventilation: physiological effects on spontaneous breathing. Respir Physiol

positive pressure ventilation for stable hypercapnic COPD. Int J Med Sci 6 (2):72-6.

Pulmonary diseases are increasingly important causes of morbidity and mortality in the modern world (Ries et al., 2007). Chronic obstructive pulmonary disease (COPD) is the most common chronic lung disease, and a major cause of lung-related death and disability (Fishman, 2008). COPD is characterized by chronic airflow limitation, progressive and largely irreversible, associated with an abnormal inflammatory reaction (Ancochea Bermúdez et al., 2009). COPD is very disabling and features extra-pulmonary manifestations, but it can be prevented and treated.

The disease is diagnosed by a clinical history based on the combination of history, physical examination and confirmation of the presence of airflow obstruction with the use of spirometry (Figure 1 Spirometry). Spirometric assessment is performed according to the guidelines of the American Thoracic Society (ATS) (Laszlo, 2006). The technician asks the subjects three exhaling exercises and the best is used for the analysis (Miller et al., 2005). If the Tiffenau rate (value of FEV1/FVC) is less than seventy percent, COPD exists (Global initiative for chronic obstructive lung disease *[GOLD],* 2010). Smoking is the major risk factor for the disease (Hilberink et al. 2011).

Fig. 1. Spirometry

Types of Physical Exercise Training for COPD Patients 353

symptoms, optimize functional status, increase participation, and reduce health-care costs by stabilizing or reversing systemic manifestations of the disease" (Nici et al., 2006). This definition focuses on three aspects of successful rehabilitation: a multidisciplinary approach; an individualized program; tailored to the patient´s needs; and attention to physical psychological and social functioning (Ries, 2008). Not forgetting a primary goal of rehabilitation interventions for people with COPD is to optimize function (Nici et al., 2006).

The components of multidisciplinary respiratory rehabilitation programs include education of patients and their families, chest physiotherapy, muscle training, the emotional support, nutritional support, occupational therapy (Ries et al., 2007). Physiotherapy consists of various phases of treatment (exercise training, peripheral and respiratory muscle training, and breathing exercises) that are considered cornerstones of the physiotherapeutic intervention (Langer et al., 2009). Also consider patients that are incorporated into a respiratory rehabilitation program must have an optimal pharmacological treatment,

There is no consensus of opinion regarding the optimal duration of the pulmonary rehabilitation intervention (Ries et al., 2007). The duration depends on changes in the patient´s lifestyle. A number of external factors also influence program duration including health-care systems and reimbursement policies, access to programs, level of functional disability, health-care provider referral patterns, and the ability of individual patients to

Few clinical trials have focused on the impact of program duration on rehabilitation outcomes, but existing data suggest that gains in exercise tolerance may be greater following longer programs (Berry et al., 2003; Foy, Rejeski, Berry, Zaccaro, & Woodard, 2001; Green, Singh, Williams, & Morgan, 2001; Troosters, Gosselink, & Decramer, 2000). Besides Verrill et al. (2005) demonstrated that patients achieved significant gains in exercise tolerance in the six minute walk distance, after twelve weeks of pulmonary rehabilitation. However, in an older trial Wijkstra et al. (1995) showed that there was no difference noted between groups in the magnitude of gains in the six minute walk distance for patients who underwent 18

Moreover, although some studies suggest that the duration of the pulmonary rehabilitation program has an impact on exercise tolerance improvement, it is not clear that other outcomes such as health status or dyspnea are similarly affected by program duration (Ries et al., 2007). Thus, given the variations found in types of rehabilitation programs and content as on duration (Clini et al., 2001). Besides the differences found in clinical study design, patient populations, health systems in different countries, program location, and

The purpose of this literature review is to compare the effectiveness of various exercises training programmes in the rehabilitation of COPD patients. This study analyzes the different types of aerobic exercises that are carried out with different intensities, doses and frequencies.

The chronic symptoms of COPD (cough, expectoration, wheezing, dyspnea and exercise tolerance) are the major factors responsible for altering the relationship between health and

although not analyzed in this chapter.

make progress toward treatment goals.

program content.

**2. Exploratory testing** 

months and three months of home-based rehabilitation.

The most common symptoms of COPD are breathlessness, chronic cough, wheezing, sputum production, recurrent respiratory infection may be associated with some of the following systematic effects such as undernourishment, weight loss, exercise limitation and muscle weakness (*GOLD,* 2010). Knowledge regarding the disturbance of muscle function that occurs in patients with COPD is continuously increasing. Initially muscular dysfunction was considered to be a self-limiting disease resulting from inactivity and lack of exercise. However, recent studies have shown that in addition to this factor, peripheral muscles such as the quadriceps seem to have some type of myopathy (Couillard & Prefaut, 2005). Although the presence of myopathy is still being debated, there is some evidence pointing to myopathy associated with oxidative stress (Rabinovich et al., 2001). Recent studies in COPD have highlighted the role of the ubiquitine proteasome system in the breakdown of skeletal muscle protein in COPD patients. Malfunction of the mitochondria has also recently been identified in these patients (Rabinovich & Vilaro, 2010).

COPD is a major cause of disability and mortality worldwide and the prevalence increases with age. COPD will increase by more than thirty percent in the next ten years, if the population does not cut down smoking (Ancochea Bermúdez et al., 2009). Actually, due to high prevalence, associated to high morbilidity, economic and social cost COPD is a major health problem (Ramsey & Sullivan, 2003; Sullivan, Ramsey, & Lee, 2000). COPD is not curable, but treatments can help to control symptoms and improve quality of life of patients. It is necessary to reduce risk factors such as smoking and physical inactivity *(GOLD,* 2010).

Many people suffer from COPD for years and die prematurely of it or its complications. The goals of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) (Rabe et al., 2007) are to improve prevention and management of COPD through a concerted worldwide effort of people involved in all facets of health care and health care policy, and to encourage an expanded level of research interest in this highly prevalent disease. The GOLD report separates COPD patients into the four different stages (figure 2) *(GOLD,* 2010).

Fig. 2. Stages for Chronic Obstructive Pulmonary Disease

Pulmonary rehabilitation has emerged as a recommended standard of care for patients with chronic lung disease based on a growing body of scientific evidence. The American Thoracic Society and European Respiratory Society (ATS /ERS) published a document in 2006 defining respiratory rehabilitation as "a multidisciplinary and comprehensive intervention has proved effective from the perspective of evidence-based medicine for patients with chronic respiratory diseases who are symptomatic and often have decreased daily life activities. Integrated into individualized treatment of the patient, pulmonary rehabilitation is designed to reduce

The most common symptoms of COPD are breathlessness, chronic cough, wheezing, sputum production, recurrent respiratory infection may be associated with some of the following systematic effects such as undernourishment, weight loss, exercise limitation and muscle weakness (*GOLD,* 2010). Knowledge regarding the disturbance of muscle function that occurs in patients with COPD is continuously increasing. Initially muscular dysfunction was considered to be a self-limiting disease resulting from inactivity and lack of exercise. However, recent studies have shown that in addition to this factor, peripheral muscles such as the quadriceps seem to have some type of myopathy (Couillard & Prefaut, 2005). Although the presence of myopathy is still being debated, there is some evidence pointing to myopathy associated with oxidative stress (Rabinovich et al., 2001). Recent studies in COPD have highlighted the role of the ubiquitine proteasome system in the breakdown of skeletal muscle protein in COPD patients. Malfunction of the mitochondria has also recently

COPD is a major cause of disability and mortality worldwide and the prevalence increases with age. COPD will increase by more than thirty percent in the next ten years, if the population does not cut down smoking (Ancochea Bermúdez et al., 2009). Actually, due to high prevalence, associated to high morbilidity, economic and social cost COPD is a major health problem (Ramsey & Sullivan, 2003; Sullivan, Ramsey, & Lee, 2000). COPD is not curable, but treatments can help to control symptoms and improve quality of life of patients. It is necessary to reduce risk factors such as smoking and physical inactivity *(GOLD,* 2010). Many people suffer from COPD for years and die prematurely of it or its complications. The goals of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) (Rabe et al., 2007) are to improve prevention and management of COPD through a concerted worldwide effort of people involved in all facets of health care and health care policy, and to encourage an expanded level of research interest in this highly prevalent disease. The GOLD report

separates COPD patients into the four different stages (figure 2) *(GOLD,* 2010).

Pulmonary rehabilitation has emerged as a recommended standard of care for patients with chronic lung disease based on a growing body of scientific evidence. The American Thoracic Society and European Respiratory Society (ATS /ERS) published a document in 2006 defining respiratory rehabilitation as "a multidisciplinary and comprehensive intervention has proved effective from the perspective of evidence-based medicine for patients with chronic respiratory diseases who are symptomatic and often have decreased daily life activities. Integrated into individualized treatment of the patient, pulmonary rehabilitation is designed to reduce

been identified in these patients (Rabinovich & Vilaro, 2010).

Fig. 2. Stages for Chronic Obstructive Pulmonary Disease

symptoms, optimize functional status, increase participation, and reduce health-care costs by stabilizing or reversing systemic manifestations of the disease" (Nici et al., 2006). This definition focuses on three aspects of successful rehabilitation: a multidisciplinary approach; an individualized program; tailored to the patient´s needs; and attention to physical psychological and social functioning (Ries, 2008). Not forgetting a primary goal of rehabilitation interventions for people with COPD is to optimize function (Nici et al., 2006).

The components of multidisciplinary respiratory rehabilitation programs include education of patients and their families, chest physiotherapy, muscle training, the emotional support, nutritional support, occupational therapy (Ries et al., 2007). Physiotherapy consists of various phases of treatment (exercise training, peripheral and respiratory muscle training, and breathing exercises) that are considered cornerstones of the physiotherapeutic intervention (Langer et al., 2009). Also consider patients that are incorporated into a respiratory rehabilitation program must have an optimal pharmacological treatment, although not analyzed in this chapter.

There is no consensus of opinion regarding the optimal duration of the pulmonary rehabilitation intervention (Ries et al., 2007). The duration depends on changes in the patient´s lifestyle. A number of external factors also influence program duration including health-care systems and reimbursement policies, access to programs, level of functional disability, health-care provider referral patterns, and the ability of individual patients to make progress toward treatment goals.

Few clinical trials have focused on the impact of program duration on rehabilitation outcomes, but existing data suggest that gains in exercise tolerance may be greater following longer programs (Berry et al., 2003; Foy, Rejeski, Berry, Zaccaro, & Woodard, 2001; Green, Singh, Williams, & Morgan, 2001; Troosters, Gosselink, & Decramer, 2000). Besides Verrill et al. (2005) demonstrated that patients achieved significant gains in exercise tolerance in the six minute walk distance, after twelve weeks of pulmonary rehabilitation. However, in an older trial Wijkstra et al. (1995) showed that there was no difference noted between groups in the magnitude of gains in the six minute walk distance for patients who underwent 18 months and three months of home-based rehabilitation.

Moreover, although some studies suggest that the duration of the pulmonary rehabilitation program has an impact on exercise tolerance improvement, it is not clear that other outcomes such as health status or dyspnea are similarly affected by program duration (Ries et al., 2007). Thus, given the variations found in types of rehabilitation programs and content as on duration (Clini et al., 2001). Besides the differences found in clinical study design, patient populations, health systems in different countries, program location, and program content.

The purpose of this literature review is to compare the effectiveness of various exercises training programmes in the rehabilitation of COPD patients. This study analyzes the different types of aerobic exercises that are carried out with different intensities, doses and frequencies.

#### **2. Exploratory testing**

The chronic symptoms of COPD (cough, expectoration, wheezing, dyspnea and exercise tolerance) are the major factors responsible for altering the relationship between health and

Types of Physical Exercise Training for COPD Patients 355

comprehensive assessment of the severity of dyspnea, combined with the Chronic Respiratory Disease Questionnaire (CRQ) incorporates five physical activities that are specific for individual patients (Guyatt et al., 1987). These instruments have been shown to be valid, reliable, and responsive (Reda, Kotz, Kocks, Wesseling, & van Schayck, 2010).

In 2004, Celli et al. created a mortality prediction index, known as the BODE index. It encompassed the body mass index (B), the degree of airflow obstruction as expressed by the FEV1 (O), dyspnea with the modified medical research council (D), and exercise (E) measured with six-minute walk distance (Table 1 Variables and point value used for the computation of BODE index) data adaptated from Celli et al. (2004). The cut-off values for the assignment of points are shown for each variable. \*The FEV1 categories were identified by the American Thoracic Society (1995).† Scored on the modified Medical Research Council (mMRC) dyspnea scale can range from 0 to 4, with a score of 4 indicating that the patient is too breathless to leave the house or becomes breathless when dressing or undressing.

Table 1. Variables and point value used for the computation of BODE index, adapted from

The BODE index is a multidimensional classification system that systemically determines the degree of mortality in individuals with COPD, that provides useful prognostic information in patients with COPD and might be able to measure health status. However, it is unknown whether the BODE index is a sensitive tool for predicting the impact of quality of life in such patients. Araujo (Araujo & Holanda, 2010) found correlations between the BODE index scores and all of the CRQ domains in COPD patients. Moreover, there are studies where patients who moved from moderate to high physical activity improved their

Over recent decades, several organizations have championed pulmonary rehabilitation and developed comprehensive statements, practice guidelines, and evidence-based guidelines (Ries, 2008), however there are differences about how assessment of severity of disease. The 2010 NICE Guidelines defended that multidimensional assessment tool (BODE index) is a better predictor of mortality and exacerbation rate than FEV1 alone (Gruffydd-Jones &

Exercise testing is frequently used in the clinical evaluation of patients with COPD to evaluate the functional impact of a treatment (American Thoracic Society & American College of Chest Physicians, 2003). Exercise testing is a useful evaluative tool, allowing standardized measurement of exertional dispnea and exercise tolerance *(GOLD,* 2010). There is, however, no consensus regarding which exercise testing protocol should be used for this application (Pepin, Saey, Whittom, LeBlanc, & Maltais, 2005). A research indicated that walking, as performed in the endurance shuttle walk, is sensitive to detect changes in exercise performance after bronchodilation (Pepin et al., 2005). Besides Pepin et al. (2007)

SGRQ scores by 18.4 and their CRQ scores by 14.8 (Esteban et al., 2010).

Celli et al. (2004)

Loveridge, 2011).

quality of life. Studies of health-related quality of life (HRQoL) in patients with COPD with varying degrees of severity have consistently shown that patients have significant decrements in HRQoL (Okubadejo, Jones, & Wedzicha, 1996; Schrier, Dekker, Kaptein, & Dijkman, 1990). Therefore, HRQoL is an important clinical outcome in COPD. The Chronic Respiratory Disease Questionnaire (CRQ) (Guyatt, Berman, Townsend, Pugsley, & Chambers, 1987) and St George´s Respirtory Questionnaire (SGRQ) (Jones, Quirk, Baveystock, & Littlejohns, 1992; Jones, 2001) are the main questionnaires used to measure the quality of life in COPD patients.

The evidence-based clinical practice guidelines document concluded that there was a strong level of type A evidence, that Pulmonary Rehabilitation Programmes (PRP) improve the symptom of dyspnea in patients with COPD with a strong level of type A evidence (Jones, 2002). Dyspnea is a sensation of respiratory discomfort and the evaluation of the degree of dyspnea provides an independent dimension that is not provided by pulmonary function tests or by measuring dyspnea in an exercise laboratory. So, dyspnea is a main symptom associated with exercise performance and, therefore, quality of life. One of the major goals of COPD treatment is a reduction in dyspnea. The severity of the disease can be determined by the intensity of dyspnea (Camargo & Pereira, 2010). The severity of COPD is habitually classified by forced expiratory volume in the first second (FEV1) after bronchodilator use (Rabe et al., 2007). Various instruments are available to measure the degree of dyspnea during exercise; the modified Medical Research Council (mMRC) dyspnea scale is the most used (Barbera et al., 2001). The mMRC has five levels that increase with the level of activity in which dyspnea appears. It assesses common tasks the patient can develop without displaying dyspnea. Levels of Dyspnea are graded as follows. Grade 0: "I only get breathless with strenuous exercise"; grade 1: "I get short of breath when hurrying or walking up a slight hill"; grade 2: "I walk slower than people of the same age because of breathlessness or have to stop for breath when walking at my own pace"; grade 3: "I stop for breath after walking 100 yards or after a few minutes"; grade 4: "I am too breathless to leave the house".

The mMRC was unidimensional, to overcome this limitation; Mahler (Mahler, Mejia-Alfaro, Ward, & Baird, 2001) designed the index known as the Baseline Dyspnea Index (BDT), which was later supplemented with the Transitional Dyspnea Index (TDI). BDT analyzes dyspnea from a triple perspective; the difficulty of the task, magnitude of effort and functional impairment, each of the sections will be assessed from 0 (severe) to 4 (none), so total amount can range between 0 and 12 (Mahler, 2006). TDI assessed changes over time compared to baseline (BDI), the changes in each of the three sections are measured between -3 and +3. Therefore, the total score can be between +9 and -9. A score of 0 indicates no changes have occurred, while -9 is very negative result (Sobradillo et al., 1999). Both multidimensional scales, BDT and TDI, are clinical instruments that can be used during cardiopulmonary exercise testing for clinical and research purposes. Besides, Borg et al., (Borg, Borg, Larsson, Letzter, & Sundblad, 2010) described the matching of the increase in dyspnea related to ventilation and oxygen consumption in exercise.

In a review of application of dyspnea and quality of life scales in COPD, it was concluded that a unidimensional scale can be used if applied in conjunction with specific quality of life scales. Alternatively, a multidimensional scale, which correlates better with quality of life, can be used (Bausewein, Farquhar, Booth, Gysels, & Higginson, 2007). Consequently, multidimensional clinical instruments were developed in order to provide a more

quality of life. Studies of health-related quality of life (HRQoL) in patients with COPD with varying degrees of severity have consistently shown that patients have significant decrements in HRQoL (Okubadejo, Jones, & Wedzicha, 1996; Schrier, Dekker, Kaptein, & Dijkman, 1990). Therefore, HRQoL is an important clinical outcome in COPD. The Chronic Respiratory Disease Questionnaire (CRQ) (Guyatt, Berman, Townsend, Pugsley, & Chambers, 1987) and St George´s Respirtory Questionnaire (SGRQ) (Jones, Quirk, Baveystock, & Littlejohns, 1992; Jones, 2001) are the main questionnaires used to measure

The evidence-based clinical practice guidelines document concluded that there was a strong level of type A evidence, that Pulmonary Rehabilitation Programmes (PRP) improve the symptom of dyspnea in patients with COPD with a strong level of type A evidence (Jones, 2002). Dyspnea is a sensation of respiratory discomfort and the evaluation of the degree of dyspnea provides an independent dimension that is not provided by pulmonary function tests or by measuring dyspnea in an exercise laboratory. So, dyspnea is a main symptom associated with exercise performance and, therefore, quality of life. One of the major goals of COPD treatment is a reduction in dyspnea. The severity of the disease can be determined by the intensity of dyspnea (Camargo & Pereira, 2010). The severity of COPD is habitually classified by forced expiratory volume in the first second (FEV1) after bronchodilator use (Rabe et al., 2007). Various instruments are available to measure the degree of dyspnea during exercise; the modified Medical Research Council (mMRC) dyspnea scale is the most used (Barbera et al., 2001). The mMRC has five levels that increase with the level of activity in which dyspnea appears. It assesses common tasks the patient can develop without displaying dyspnea. Levels of Dyspnea are graded as follows. Grade 0: "I only get breathless with strenuous exercise"; grade 1: "I get short of breath when hurrying or walking up a slight hill"; grade 2: "I walk slower than people of the same age because of breathlessness or have to stop for breath when walking at my own pace"; grade 3: "I stop for breath after walking 100 yards or after a few minutes"; grade 4: "I am too breathless to leave the house". The mMRC was unidimensional, to overcome this limitation; Mahler (Mahler, Mejia-Alfaro, Ward, & Baird, 2001) designed the index known as the Baseline Dyspnea Index (BDT), which was later supplemented with the Transitional Dyspnea Index (TDI). BDT analyzes dyspnea from a triple perspective; the difficulty of the task, magnitude of effort and functional impairment, each of the sections will be assessed from 0 (severe) to 4 (none), so total amount can range between 0 and 12 (Mahler, 2006). TDI assessed changes over time compared to baseline (BDI), the changes in each of the three sections are measured between -3 and +3. Therefore, the total score can be between +9 and -9. A score of 0 indicates no changes have occurred, while -9 is very negative result (Sobradillo et al., 1999). Both multidimensional scales, BDT and TDI, are clinical instruments that can be used during cardiopulmonary exercise testing for clinical and research purposes. Besides, Borg et al., (Borg, Borg, Larsson, Letzter, & Sundblad, 2010) described the matching of the increase in

dyspnea related to ventilation and oxygen consumption in exercise.

In a review of application of dyspnea and quality of life scales in COPD, it was concluded that a unidimensional scale can be used if applied in conjunction with specific quality of life scales. Alternatively, a multidimensional scale, which correlates better with quality of life, can be used (Bausewein, Farquhar, Booth, Gysels, & Higginson, 2007). Consequently, multidimensional clinical instruments were developed in order to provide a more

the quality of life in COPD patients.

comprehensive assessment of the severity of dyspnea, combined with the Chronic Respiratory Disease Questionnaire (CRQ) incorporates five physical activities that are specific for individual patients (Guyatt et al., 1987). These instruments have been shown to be valid, reliable, and responsive (Reda, Kotz, Kocks, Wesseling, & van Schayck, 2010).

In 2004, Celli et al. created a mortality prediction index, known as the BODE index. It encompassed the body mass index (B), the degree of airflow obstruction as expressed by the FEV1 (O), dyspnea with the modified medical research council (D), and exercise (E) measured with six-minute walk distance (Table 1 Variables and point value used for the computation of BODE index) data adaptated from Celli et al. (2004). The cut-off values for the assignment of points are shown for each variable. \*The FEV1 categories were identified by the American Thoracic Society (1995).† Scored on the modified Medical Research Council (mMRC) dyspnea scale can range from 0 to 4, with a score of 4 indicating that the patient is too breathless to leave the house or becomes breathless when dressing or undressing.


Table 1. Variables and point value used for the computation of BODE index, adapted from Celli et al. (2004)

The BODE index is a multidimensional classification system that systemically determines the degree of mortality in individuals with COPD, that provides useful prognostic information in patients with COPD and might be able to measure health status. However, it is unknown whether the BODE index is a sensitive tool for predicting the impact of quality of life in such patients. Araujo (Araujo & Holanda, 2010) found correlations between the BODE index scores and all of the CRQ domains in COPD patients. Moreover, there are studies where patients who moved from moderate to high physical activity improved their SGRQ scores by 18.4 and their CRQ scores by 14.8 (Esteban et al., 2010).

Over recent decades, several organizations have championed pulmonary rehabilitation and developed comprehensive statements, practice guidelines, and evidence-based guidelines (Ries, 2008), however there are differences about how assessment of severity of disease. The 2010 NICE Guidelines defended that multidimensional assessment tool (BODE index) is a better predictor of mortality and exacerbation rate than FEV1 alone (Gruffydd-Jones & Loveridge, 2011).

Exercise testing is frequently used in the clinical evaluation of patients with COPD to evaluate the functional impact of a treatment (American Thoracic Society & American College of Chest Physicians, 2003). Exercise testing is a useful evaluative tool, allowing standardized measurement of exertional dispnea and exercise tolerance *(GOLD,* 2010). There is, however, no consensus regarding which exercise testing protocol should be used for this application (Pepin, Saey, Whittom, LeBlanc, & Maltais, 2005). A research indicated that walking, as performed in the endurance shuttle walk, is sensitive to detect changes in exercise performance after bronchodilation (Pepin et al., 2005). Besides Pepin et al. (2007)

Types of Physical Exercise Training for COPD Patients 357

test. Physicians should obtain the results of previous evaluations, where possible, to compare with the current clinical data. Specific information is required on the frequency and severity of attacks of breathlessness and cough, sputum volume and color, and limitation of

Other targets of rehabilitation are anxiety control, dyspnea reduction and improvement of the health-related quality of life (Lacasse et al., 2006). The illness evolution can be associated with extra-pulmonary components, such as muscle loss is related with reduction of physical activity. After exacerbation, symptoms of depression have been identified as an independent factor of mortality risk (Yohannes, Baldwin, & Connolly, 2005), as well as risk a factor for rehabilitation program drop-outs (Garrod, Marshall, Barley, & Jones, 2006). The skeletal muscle dysfunction and depressive symptoms are potencially amenable to rehabilitation with exercise training (Rodrigues, 2010). We have made the following figure 3 in order to collect intra-pulmonary components (airways obstruction and dyspnea) with extra-pulmonary factors (muscle wasting, reduce mobility, exercise limitation, depression

Fig. 3. Relation between intra-pulmonary components with extra-pulmonary factors.

Physical activity is defined as any bodily movement produced by skeletal muscles that results in energy expenditure beyond resting energy expenditure (Thompson et al., 2003). Information on the importance of physical activity in COPD has grown, especially in the last few years, although major questions remain to be answered. The present chapter aims to provide an update on the most important studies of physical activity in COPD (Esteban,

Findings from meta-analysis of pulmonary rehabilitation strongly supports that exercise training as part of treatment of patients with COPD should last at least four weeks (Lacasse, Goldstein, Lasserson, & Martin, 2006). Exercise training should be available to people with COPD, because it improves breathlessness, quality of life, exercise tolerance and functional ability (Lacasse et al., 2006). Physical therapists are crucial to the delivery of rehabilitation because of their training in exercise and movement therapies (Garrod & Lasserson, 2007).

The primary goal of the rehabilitation programs is to restore the patient to the highest possible level of independent function (Ries et al., 2007). This goal is accomplished by

daily activities (Vilaró et al., 2007).

and sedentary lifestyle).

**3. Types of exercises** 

2009).

indicate that the response of the 6MWT test is not sensitive to change and may not be appropriate for an assessment tool. Another research also suggests that the endurance shuttle walk is more responsive to the effects of pulmonary rehabilitation than the 6MWT for detecting changes in exercise performance following broncholdilations (Eaton, Young, Nicol, & Kolbe, 2006). Together, these findings provide growing support for the use of the endurance shuttle walk as an evaluative tool to monitor response to treatment to COPD.

The six minute walk test (6MWT) is used in order to determine the six-minute walk distance (6MWD), which correlates with the performance of activities of daily living in patients with COPD (ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories, 2002; Brooks, Solway, & Gibbons, 2003). The 6MWT measures the global and integrated responses of all organ systems involved during exercise, has been shown to be an important parameter related to morbility and mortality in COPD (Casanova et al., 2007), and is also part of the BODE index (Celli et al., 2004). Although rehabilitation improves both exercise tolerance and quality of life in COPD, it is not known whether these improvements are related to each other. Several trials show the weak correlation between quality of life and the six minute walking distance in patients with COPD suggests that these parameters measure different aspects of health (Wijkstra et al., 1995).

Recently, the use of accelerometer has been incorporated as an objective measure to assess physical activity level of the patient performs daily (Troosters et al., 2010). It is necessary to analyze physical activity in daily life in patients across different disease stages according to GOLD. Other studies have shown that grip strength in the wrist is a strong independent predictor of mortality in COPD (Cortopassi, Divo, Pinto-Plata, & Celli, 2011). A significant relationship was found between hand grip strength and peripheral muscle strength (flexion of elbow and knee) and strong relationship (r = - 0.75, p <0.0001) with the force respiratory muscles (maximum inspiratory muscles, inspiratory capacity, forced vital capacity and maximum volume ventilation).

There is no clinical trial review that has found a connection between rehabilitation respiratory programs and an increase in exercise tolerance. It is necessary to clarify the change in quality of life was related with a change in exercise tolerance in COPD patients. The difference between current studies and previous controlled studies (Sinclair, 1980; Vale, Reardon, & ZuWallack, 1993) are the use of the 12 minute walking distance which is probably more sensitive to change than the six minute walking distance (Wijkstra et al., 1995).

COPD is often associated with exacerbation of symptoms. An exacerbation of COPD is defined as "an event in the natural course for the disease characterized by a change in the patient´s baseline dyspnea, cough, and/or sputum that is beyond normal day-to-day variations, is acute in onset, and may warrant a change in regular medication in a patient with underlying COPD" (Burge & Wedzicha, 2003). The most common causes of an exacerbation are infection of the tracheobronchial tree and air pollution (White, Gompertz, & Stockley, 2003). Studies investigating effects on pulmonary function and oxigenation did not show benefits in either acute exacerbations of COPD (Newton & Bevans, 1978) or in chronic COPD (May & Munt, 1979). Assessment of the severity of an exacerbation is based on the patient´s medical history before the exacerbation, pre-existing comorbidities, symptoms, physical examination, arterial blood gas measurements, and other laboratory

indicate that the response of the 6MWT test is not sensitive to change and may not be appropriate for an assessment tool. Another research also suggests that the endurance shuttle walk is more responsive to the effects of pulmonary rehabilitation than the 6MWT for detecting changes in exercise performance following broncholdilations (Eaton, Young, Nicol, & Kolbe, 2006). Together, these findings provide growing support for the use of the endurance shuttle walk as an evaluative tool to monitor response to treatment to COPD.

The six minute walk test (6MWT) is used in order to determine the six-minute walk distance (6MWD), which correlates with the performance of activities of daily living in patients with COPD (ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories, 2002; Brooks, Solway, & Gibbons, 2003). The 6MWT measures the global and integrated responses of all organ systems involved during exercise, has been shown to be an important parameter related to morbility and mortality in COPD (Casanova et al., 2007), and is also part of the BODE index (Celli et al., 2004). Although rehabilitation improves both exercise tolerance and quality of life in COPD, it is not known whether these improvements are related to each other. Several trials show the weak correlation between quality of life and the six minute walking distance in patients with COPD suggests that these parameters

Recently, the use of accelerometer has been incorporated as an objective measure to assess physical activity level of the patient performs daily (Troosters et al., 2010). It is necessary to analyze physical activity in daily life in patients across different disease stages according to GOLD. Other studies have shown that grip strength in the wrist is a strong independent predictor of mortality in COPD (Cortopassi, Divo, Pinto-Plata, & Celli, 2011). A significant relationship was found between hand grip strength and peripheral muscle strength (flexion of elbow and knee) and strong relationship (r = - 0.75, p <0.0001) with the force respiratory muscles (maximum inspiratory muscles, inspiratory capacity, forced vital capacity and

There is no clinical trial review that has found a connection between rehabilitation respiratory programs and an increase in exercise tolerance. It is necessary to clarify the change in quality of life was related with a change in exercise tolerance in COPD patients. The difference between current studies and previous controlled studies (Sinclair, 1980; Vale, Reardon, & ZuWallack, 1993) are the use of the 12 minute walking distance which is probably more sensitive to change than the six minute walking distance (Wijkstra et al.,

COPD is often associated with exacerbation of symptoms. An exacerbation of COPD is defined as "an event in the natural course for the disease characterized by a change in the patient´s baseline dyspnea, cough, and/or sputum that is beyond normal day-to-day variations, is acute in onset, and may warrant a change in regular medication in a patient with underlying COPD" (Burge & Wedzicha, 2003). The most common causes of an exacerbation are infection of the tracheobronchial tree and air pollution (White, Gompertz, & Stockley, 2003). Studies investigating effects on pulmonary function and oxigenation did not show benefits in either acute exacerbations of COPD (Newton & Bevans, 1978) or in chronic COPD (May & Munt, 1979). Assessment of the severity of an exacerbation is based on the patient´s medical history before the exacerbation, pre-existing comorbidities, symptoms, physical examination, arterial blood gas measurements, and other laboratory

measure different aspects of health (Wijkstra et al., 1995).

maximum volume ventilation).

1995).

test. Physicians should obtain the results of previous evaluations, where possible, to compare with the current clinical data. Specific information is required on the frequency and severity of attacks of breathlessness and cough, sputum volume and color, and limitation of daily activities (Vilaró et al., 2007).

Other targets of rehabilitation are anxiety control, dyspnea reduction and improvement of the health-related quality of life (Lacasse et al., 2006). The illness evolution can be associated with extra-pulmonary components, such as muscle loss is related with reduction of physical activity. After exacerbation, symptoms of depression have been identified as an independent factor of mortality risk (Yohannes, Baldwin, & Connolly, 2005), as well as risk a factor for rehabilitation program drop-outs (Garrod, Marshall, Barley, & Jones, 2006). The skeletal muscle dysfunction and depressive symptoms are potencially amenable to rehabilitation with exercise training (Rodrigues, 2010). We have made the following figure 3 in order to collect intra-pulmonary components (airways obstruction and dyspnea) with extra-pulmonary factors (muscle wasting, reduce mobility, exercise limitation, depression and sedentary lifestyle).

Fig. 3. Relation between intra-pulmonary components with extra-pulmonary factors.
